1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
2
|
Ferlay J, Soerjomataram I, Dikshit R, Eser
S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer
incidence and mortality worldwide: Sources, methods and major
patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015.
View Article : Google Scholar : PubMed/NCBI
|
3
|
Wang W, Jia HL, Huang JM, Liang YC, Tan H,
Geng HZ, Guo LY and Yao SZ: Identification of biomarkers for lymph
node metastasis in early-stage cervical cancer by tissue-based
proteomics. Br J Cancer. 110:1748–1758. 2014. View Article : Google Scholar : PubMed/NCBI
|
4
|
Fleming ND, Frumovitz M, Schmeler KM, dos
Reis R, Munsell MF, Eifel PJ, Soliman PT, Nick AM, Westin SN and
Ramirez PT: Significance of lymph node ratio in defining risk
category in node-positive early stage cervical cancer. Gynecol
Oncol. 136:48–53. 2015. View Article : Google Scholar : PubMed/NCBI
|
5
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2013. CA Cancer J Clin. 63:11–30. 2013. View Article : Google Scholar : PubMed/NCBI
|
6
|
Ying TH, Lee CH, Chiou HL, Yang SF, Lin
CL, Hung CH, Tsai JP and Hsieh YH: Knockdown of Pentraxin 3
suppresses tumorigenicity and metastasis of human cervical cancer
cells. Sci Rep. 6:293852016. View Article : Google Scholar : PubMed/NCBI
|
7
|
Xin M, Qiao Z, Li J, Liu J, Song S, Zhao
X, Miao P, Tang T, Wang L, Liu W, et al: miR-22 inhibits tumor
growth and metastasis by targeting ATP citrate lyase: Evidence in
osteosarcoma, prostate cancer, cervical cancer and lung cancer.
Oncotarget. 7:44252–44265. 2016.PubMed/NCBI
|
8
|
Zhou Q, Han LR, Zhou YX and Li Y: MiR-195
suppresses cervical cancer migration and invasion through targeting
Smad3. Int J Gynecol Cancer. 26:817–824. 2016. View Article : Google Scholar : PubMed/NCBI
|
9
|
Mattick JS: The genetic signatures of
noncoding RNAs. PLoS Genet. 5:e10004592009. View Article : Google Scholar : PubMed/NCBI
|
10
|
Rinn JL and Chang HY: Genome regulation by
long noncoding RNAs. Annu Rev Biochem. 81:145–166. 2012. View Article : Google Scholar : PubMed/NCBI
|
11
|
Wang Y, Zhong H, Xie X, Chen CY, Huang D,
Shen L, Zhang H, Chen ZW and Zeng G: Long noncoding RNA derived
from CD244 signaling epigenetically controls CD8+ T-cell immune
responses in tuberculosis infection. Proc Natl Acad Sci USA.
112:E3883–E3892. 2015. View Article : Google Scholar : PubMed/NCBI
|
12
|
Carlson HL, Quinn JJ, Yang YW, Thornburg
CK, Chang HY and Stadler HS: LncRNA-HIT functions as an epigenetic
regulator of chondrogenesis through its recruitment of p100/CBP
complexes. PLoS Genet. 11:e10056802015. View Article : Google Scholar : PubMed/NCBI
|
13
|
Zhou C, York SR, Chen JY, Pondick JV,
Motola DL, Chung RT and Mullen AC: Long noncoding RNAs expressed in
human hepatic stellate cells form networks with extracellular
matrix proteins. Genome Med. 8:312016. View Article : Google Scholar : PubMed/NCBI
|
14
|
Schmitz SU, Grote P and Herrmann BG:
Mechanisms of long noncoding RNA function in development and
disease. Cell Mol Life Sci. 73:2491–2509. 2016. View Article : Google Scholar : PubMed/NCBI
|
15
|
Takahashi K, Yan I, Haga H and Patel T:
Long noncoding RNA in liver diseases. Hepatology. 60:744–753. 2014.
View Article : Google Scholar : PubMed/NCBI
|
16
|
Chen Z, Luo Y, Yang W, Ding L, Wang J, Tu
J, Geng B, Cui Q and Yang J: Comparison analysis of dysregulated
LncRNA profile in mouse plasma and liver after hepatic
ischemia/reperfusion injury. PLoS One. 10:e01334622015. View Article : Google Scholar : PubMed/NCBI
|
17
|
Li P, Zhang G, Li J, Yang R, Chen S, Wu S,
Zhang F, Bai Y, Zhao H, Wang Y, et al: Long noncoding RNA RGMB-AS1
indicates a poor prognosis and modulates cell proliferation,
migration and invasion in lung adenocarcinoma. PLoS One.
11:e01507902016. View Article : Google Scholar : PubMed/NCBI
|
18
|
Li G, Zhang H, Wan X, Yang X, Zhu C, Wang
A, He L, Miao R, Chen S and Zhao H: Long noncoding RNA plays a key
role in metastasis and prognosis of hepatocellular carcinoma.
Biomed Res Int. 2014:7805212014.PubMed/NCBI
|
19
|
Liu T, Zhang X, Yang YM, Du LT and Wang
CX: Increased expression of the long noncoding RNA CRNDE-h
indicates a poor prognosis in colorectal cancer, and is positively
correlated with IRX5 mRNA expression. Onco Targets Ther.
9:1437–1448. 2016.PubMed/NCBI
|
20
|
Kong J, Sun W, Li C, Wan L, Wang S, Wu Y,
Xu E, Zhang H and Lai M: Long non-coding RNA LINC01133 inhibits
epithelial-mesenchymal transition and metastasis in colorectal
cancer by interacting with SRSF6. Cancer Lett. 380:476–484. 2016.
View Article : Google Scholar : PubMed/NCBI
|
21
|
Chen S, Wu H, Lv N, Wang H, Wang Y, Tang
Q, Shao H and Sun C: LncRNA CCAT2 predicts poor prognosis and
regulates growth and metastasis in small cell lung cancer. Biomed
Pharmacother. 82:583–588. 2016. View Article : Google Scholar : PubMed/NCBI
|
22
|
Dong R, Liu GB, Liu BH, Chen G, Li K,
Zheng S and Dong KR: Targeting long non-coding RNA-TUG1 inhibits
tumor growth and angiogenesis in hepatoblastoma. Cell Death Dis.
7:e22782016. View Article : Google Scholar : PubMed/NCBI
|
23
|
Wang Y, Li Z, Zheng S, Zhou Y, Zhao L, Ye
H, Zhao X, Gao W, Fu Z, Zhou Q, et al: Expression profile of long
non-coding RNAs in pancreatic cancer and their clinical
significance as biomarkers. Oncotarget. 6:35684–35698.
2015.PubMed/NCBI
|
24
|
Quagliata L, Matter MS, Piscuoglio S,
Arabi L, Ruiz C, Procino A, Kovac M, Moretti F, Makowska Z,
Boldanova T, et al: Long noncoding RNA HOTTIP/HOXA13 expression is
associated with disease progression and predicts outcome in
hepatocellular carcinoma patients. Hepatology. 59:911–923. 2014.
View Article : Google Scholar : PubMed/NCBI
|
25
|
Li J, Huang H, Li Y, Li L, Hou W and You
Z: Decreased expression of long non-coding RNA GAS5 promotes cell
proliferation, migration and invasion, and indicates a poor
prognosis in ovarian cancer. Oncol Rep. 36:3241–3250.
2016.PubMed/NCBI
|
26
|
Arbyn M, Castellsagué X, de Sanjosé S,
Bruni L, Saraiya M, Bray F and Ferlay J: Worldwide burden of
cervical cancer in 2008. Ann Oncol. 22:2675–2686. 2011. View Article : Google Scholar : PubMed/NCBI
|
27
|
Kotake Y, Nakagawa T, Kitagawa K, Suzuki
S, Liu N, Kitagawa M and Xiong Y: Long non-coding RNA ANRIL is
required for the PRC2 recruitment to and silencing of p15INK4B
tumor suppressor gene. Oncogene. 30:1956–1962. 2011. View Article : Google Scholar : PubMed/NCBI
|
28
|
Liu Y, Zhao J, Zhang W, Gan J, Hu C, Huang
G and Zhang Y: lncRNA GAS5 enhances G1 cell cycle arrest via
binding to YBX1 to regulate p21 expression in stomach cancer. Sci
Rep. 5:101592015. View Article : Google Scholar : PubMed/NCBI
|
29
|
Pan Y, Li G, Zhong H, Chen M, Chen T, Gao
L, Wu H and Guo J: RIG-I inhibits pancreatic β cell proliferation
through competitive binding of activated Src. Sci Rep. 6:289142016.
View Article : Google Scholar : PubMed/NCBI
|
30
|
Hrdlickova B, De Almeida RC, Borek Z and
Withoff S: Genetic variation in the non-coding genome: Involvement
of micro-RNAs and long non-coding RNAs in disease. Biochim Biophys
Acta. 1842:1910–1922. 2014. View Article : Google Scholar : PubMed/NCBI
|
31
|
Kung JT, Colognori D and Lee JT: Long
noncoding RNAs: Past, present, and future. Genetics. 193:651–669.
2013. View Article : Google Scholar : PubMed/NCBI
|
32
|
Cao S, Liu W, Li F, Zhao W and Qin C:
Decreased expression of lncRNA GAS5 predicts a poor prognosis in
cervical cancer. Int J Clin Exp Pathol. 7:6776–6783.
2014.PubMed/NCBI
|
33
|
Yang M, Zhai X, Xia B, Wang Y and Lou G:
Long noncoding RNA CCHE1 promotes cervical cancer cell
proliferation via upregulating PCNA. Tumour Biol. 36:7615–7622.
2015. View Article : Google Scholar : PubMed/NCBI
|
34
|
Kim HJ, Lee DW, Yim GW, Nam EJ, Kim S, Kim
SW and Kim YT: Long non-coding RNA HOTAIR is associated with human
cervical cancer progression. Int J Oncol. 46:521–530.
2015.PubMed/NCBI
|
35
|
Congdon LM, Houston SI, Veerappan CS,
Spektor TM and Rice JC: PR-Set7-mediated monomethylation of histone
H4 lysine 20 at specific genomic regions induces transcriptional
repression. J Cell Biochem. 110:609–619. 2010. View Article : Google Scholar : PubMed/NCBI
|
36
|
Li Z, Nie F, Wang S and Li L: Histone H4
Lys 20 monomethylation by histone methylase SET8 mediates Wnt
target gene activation. Proc Natl Acad Sci USA. 108:3116–3123.
2011. View Article : Google Scholar : PubMed/NCBI
|
37
|
Houston SI, McManus KJ, Adams MM, Sims JK,
Carpenter PB, Hendzel MJ and Rice JC: Catalytic function of the
PR-Set7 histone H4 lysine 20 monomethyltransferase is essential for
mitotic entry and genomic stability. J Biol Chem. 283:19478–19488.
2008. View Article : Google Scholar : PubMed/NCBI
|
38
|
Oda H, Okamoto I, Murphy N, Chu J, Price
SM, Shen MM, Torres-Padilla ME, Heard E and Reinberg D:
Monomethylation of histone H4-lysine 20 is involved in chromosome
structure and stability and is essential for mouse development. Mol
Cell Biol. 29:2278–2295. 2009. View Article : Google Scholar : PubMed/NCBI
|
39
|
Jørgensen S, Elvers I, Trelle MB, Menzel
T, Eskildsen M, Jensen ON, Helleday T, Helin K and Sørensen CS: The
histone methyltransferase SET8 is required for S-phase progression.
J Cell Biol. 179:1337–1345. 2007. View Article : Google Scholar : PubMed/NCBI
|
40
|
Centore RC, Havens CG, Manning AL, Li JM,
Flynn RL, Tse A, Jin J, Dyson NJ, Walter JC and Zou L:
CRL4Cdt2-mediated destruction of the histone methyltransferase Set8
prevents premature chromatin compaction in S phase. Mol Cell.
40:22–33. 2010. View Article : Google Scholar : PubMed/NCBI
|
41
|
Sanders SL, Portoso M, Mata J, Bähler J,
Allshire RC and Kouzarides T: Methylation of histone H4 lysine 20
controls recruitment of Crb2 to sites of DNA damage. Cell.
119:603–614. 2004. View Article : Google Scholar : PubMed/NCBI
|
42
|
Oda H, Hübner MR, Beck DB, Vermeulen M,
Hurwitz J, Spector DL and Reinberg D: Regulation of the histone H4
monomethylase PR-Set7 by CRL4Cdt2-mediated PCNA-dependent
degradation during DNA damage. Mol Cell. 40:364–376. 2010.
View Article : Google Scholar : PubMed/NCBI
|
43
|
Yu N, Huangyang P, Yang X, Han X, Yan R,
Jia H, Shang Y and Sun L: microRNA-7 suppresses the invasive
potential of breast cancer cells and sensitizes cells to DNA
damages by targeting histone methyltransferase SET8. J Biol Chem.
288:19633–19642. 2013. View Article : Google Scholar : PubMed/NCBI
|